- New
-
Topics
- All Categories
- Metaphysics and Epistemology
- Value Theory
- Science, Logic, and Mathematics
- Science, Logic, and Mathematics
- Logic and Philosophy of Logic
- Philosophy of Biology
- Philosophy of Cognitive Science
- Philosophy of Computing and Information
- Philosophy of Mathematics
- Philosophy of Physical Science
- Philosophy of Social Science
- Philosophy of Probability
- General Philosophy of Science
- Philosophy of Science, Misc
- History of Western Philosophy
- Philosophical Traditions
- Philosophy, Misc
- Other Academic Areas
- Journals
- Submit material
- More
Corruption of Pharmaceutical Markets: Addressing the Misalignment of Financial Incentives and Public Health
Journal of Law, Medicine and Ethics 41 (3):571-580 (2013)
Abstract
This article argues that the misalignment of private profit-maximizing objectives with public health needs causes institutional corruption in the pharmaceutical sector and systematically leads firms to act contrary to public heath. The article analyzes how financial incentives generate a business model promoting harmful practices and explores several means of realigning financial incentives in order to foster therapeutic innovation and promote the rational use of medicines.My notes
Similar books and articles
Corruption of Pharmaceutical Markets: Addressing the Misalignment of Financial Incentives and Public Health.Marc-André Gagnon - 2013 - Journal of Law, Medicine and Ethics 41 (3):571-580.
The Law, Policy, and Ethics of Employers' Use of Financial Incentives to Improve Health.Kristin M. Madison, Kevin G. Volpp & Scott D. Halpern - 2011 - Journal of Law, Medicine and Ethics 39 (3):450-468.
Comment on ‘Paying People to Act in Their Own Interests: Incentives versus Rationalisation in Public Health’ by Jonathan Wolff.Mathias Kifmann - 2015 - Public Health Ethics 8 (1):31-33.
Effect of Financial Relationships on the Behaviors of Health Care Professionals: A Review of the Evidence. [REVIEW]Christopher Robertson, Susannah Rose & Aaron S. Kesselheim - 2012 - Journal of Law, Medicine and Ethics 40 (3):452-466.
Masked ball: Ethics, laws and financial contradictions in hungarian health care.Imre Szebik - 2003 - Science and Engineering Ethics 9 (1):109-124.
Public Perceptions of Health Care Professionals' Participation in Pharmaceutical Marketing.Nancy J. Crigger, Laura Courter, Kristen Hayes & K. Shepherd - 2009 - Nursing Ethics 16 (5):647-658.
Human rights and global health: A research program.Thomas W. Pogge - 2005 - Metaphilosophy 36 (1‐2):182-209.
‘I Did it For the Money’: Incentives, Rationalizations and Health.Moti Gorin & Harald Schmidt - 2015 - Public Health Ethics 8 (1):34-41.
Impact of gender and professional education on attitudes towards financial incentives for organ donation: results of a survey among 755 students of medicine and economics in Germany.Julia Inthorn, Sabine Wöhlke, Fabian Schmidt & Silke Schicktanz - 2014 - BMC Medical Ethics 15 (1):56.
Pharmaceuticals, Political Money, and Public Policy: A Theoretical and Empirical Agenda.Paul D. Jorgensen - 2013 - Journal of Law, Medicine and Ethics 41 (3):561-570.
Improving ethical review of research involving incentives for health promotion.Alex John London, David A. Borasky & Anant Bhan - unknown
Ethics and the Business of Biomedicine.Denis Gordon Arnold (ed.) - 2009 - New York: Cambridge University Press.
Toward a More Stable Blood Supply: Charitable Incentives, Donation Rates, and the Experience of September 11.Reuben G. Sass - 2013 - American Journal of Bioethics 13 (6):38-45.
Analytics
Added to PP
2016-02-04
Downloads
35 (#454,663)
6 months
16 (#154,895)
2016-02-04
Downloads
35 (#454,663)
6 months
16 (#154,895)
Historical graph of downloads
Citations of this work
Institutional Corruption of Pharmaceuticals and the Myth of Safe and Effective Drugs.Donald W. Light, Joel Lexchin & Jonathan J. Darrow - 2013 - Journal of Law, Medicine and Ethics 41 (3):590-600.
Institutional Corruption of Pharmaceuticals and the Myth of Safe and Effective Drugs.Donald W. Light, Joel Lexchin & Jonathan J. Darrow - 2013 - Journal of Law, Medicine and Ethics 41 (3):590-600.
Five Un-Easy Pieces of Pharmaceutical Policy Reform.Marc A. Rodwin - 2013 - Journal of Law, Medicine and Ethics 41 (3):581-589.
Five Un‐Easy Pieces of Pharmaceutical Policy Reform.Marc A. Rodwin - 2013 - Journal of Law, Medicine and Ethics 41 (3):581-589.
References found in this work
Corporate Crime in the Pharmaceutical Industry (Routledge Revivals).John Braithwaite - 2013 - Routledge.
Ghost management: How much of the medical literature is shaped behind the scenes by the pharmaceutical industry?Sergio Sismondo - manuscript
Rooting Out Institutional Corruption to Manage Inappropriate Off-Label Drug Use.Marc A. Rodwin - 2013 - Journal of Law, Medicine and Ethics 41 (3):654-664.
Rooting Out Institutional Corruption to Manage Inappropriate Off‐Label Drug Use.Marc A. Rodwin - 2013 - Journal of Law, Medicine and Ethics 41 (3):654-664.
PhilPapers logo by Andrea Andrews and Meghan Driscoll.
This site uses cookies and Google Analytics (see our terms & conditions for details regarding the privacy implications). Use of this site is subject to terms & conditions.
All rights reserved by The PhilPapers Foundation
Server: philpapers-web-64dd777598-vk9kt uwo